Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sub Q Maintenance Success Set To Improve Entyvio's Position In Ulcerative Colitis

Executive Summary

New positive data with more convenient formulation set stage for increased Entyvio competitiveness in ulcerative colitis maintenance setting, while other early results bode well for Ninlaro in maintenance use in multiple myeloma.

Advertisement

Related Content

Ninlaro Looking Positive In MM Maintenance On Back Of TOURMALINE Data
Takeda Offers Shire Asset Disposal To Assuage EC Merger Concerns
Latest Japan Approvals Include Entyvio, Imfinzi, World-First Indication
Takeda Looks To The New As It Braces For Velcade Generics

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123459

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel